-
Sep 17 |
Diagnostics World | Ovarian cancer relapse is a remarkably diverse and dynamic immunological event that when mapped in conjunction with the genomic characteristic of tumors can provide actionable insights about how to enhance the effectiveness of chemotherapy in extending remission and prolonging survival. That’s the promising possibility suggested by researchers in the field who have newly defined four immunologic subtypes of recurrent ovarian cancers.
More
-
Sep 16 |
Diagnostics World | Results from one of the largest randomized evaluations of AI in routine care showed that an AI-enabled digital stethoscope significantly increased the number of major cardiac conditions detected compared to the standard of care. The study was led by Imperial College London and Imperial College Healthcare NHS Trust and the results were presented last week at the European Society of Cardiology Congress in Madrid.
More
-
Sep 11 |
Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.
More
-
Sep 09 |
Diagnostics World | There is a lack of reliable predictive methods that can determine how a patient will respond to certain immunotherapies and understanding how immune cells communicate with each other may be the key to understanding the differences. A team of researchers have created a new technology called Interact-omics that can “listen in” on this immune cell dialogue.
More
-
Sep 04 |
Diagnostics World | In a lively matchup between clinical microbiology experts at the recent Next-Generation Dx Summit, onlookers already predisposed to believing artificial intelligence (AI) would not be replacing conventional microbiology and infectious disease testing in the next 10 years were further swayed toward dismissing the possibility. It perhaps helped that the deciding vote on the debate came immediately after the person arguing mightily about the inevitability of an AI takeover himself switched from the affirmative to the negative position.
More
-
Sep 03 |
Diagnostics World | An assortment of “hot-button issues” in point-of-care testing (POCT) remain to be sorted out amid rising patient demand for access to rapid and reliable tests results, mounting financial pressures on healthcare systems, and ongoing concerns about the setting and timing of testing to reap the most clinical benefits. Having actionable results, improving connections to care, and balancing patient anonymity with public health reporting in sexually transmitted infection (STI) testing are among the current topics of dialogue, as highlighted during the Next-Generation Dx Summit held last month.
More
-
Sep 02 |
Diagnostics World | When it comes to disease diagnostics, every missed genetic variant represents a delay in diagnosis—and often in treatment. Researchers at Pacific Biosciences (PacBio) developed a new genomic benchmark that could help close those diagnostic gaps, offering more accurate detection of genetic variants.
More
-
Aug 27 |
Diagnostics World | Strand Therapeutics will advance their pipeline of STX-001, a programmable mRNA therapy that expresses the cytokine interleukin-12 (IL-12) directly from the tumor microenvironment; Jocasta Therapeutics plan to further develop a - Klotho, a protein therapeutic targeting cognitive decline in neurodegenerative diseases; and more.
More
-
Aug 26 |
Diagnostics World | Roche announced the US Food and Drug Administration (FDA) 510(k) clearance for the cobas Respiratory 4-flex; Dana-Farber Cancer Institute researchers have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma; and more.
More
-
Aug 21 |
Diagnostics World | Earlier this month, Boston Children’s Hospital, Broad Clinical Labs, and Dana-Farber Cancer Institute announced the formation of a collaborative clinical research and testing initiative, Boston Research in Innovative Genomics for Hematologic and Tumor Sequencing (BrightSeq).
More
-
Sep 16 |
AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform
More
-
Sep 12 |
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.
More
-
Sep 12 |
Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.
More
-
Sep 12 |
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A. The updated assay will ensure labs are ready and able to deliver accurate results when new treatments become available.
More
-
Sep 12 |
For participating academic medical centers, healthcare systems, and reference laboratories, Proscia Aperture elevates pathology from a diagnostic function to a strategic revenue driver.
More
-
Sep 12 |
UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.
More
-
Sep 12 |
• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
• Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency
More
-
Sep 05 |
Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.
More
-
Sep 04 |
One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.
More
-
Sep 04 |
More
View more articles